Products
Platform
Research
Market
Learn
Compare Tata Nifty MidSmall Healthcare Index Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.11 | 1.93 |
NAV | ₹12.66 | ₹431.48 |
Fund Started | 08 Apr 2024 | 04 Jun 1999 |
Fund Size | ₹160.07 Cr | ₹4082.13 Cr |
Exit Load | Exit load of 0.25%, if redeemed within 15 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.11
1.93
NAV
₹12.66
₹431.48
Fund Started
08 Apr 2024
04 Jun 1999
Fund Size
₹160.07 Cr
₹4082.13 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 3.94% | 3.35% |
3 Year | - | 23.77% |
5 Year | - | 18.53% |
1 Year
3.94%
3.35%
3 Year
-
23.77%
5 Year
-
18.53%
Holding Analysis
Equity | 100.08% | 96.05% |
Cash | -0.08% | 3.88% |
Equity
100.08%
96.05%
Cash
-0.08%
3.88%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Fortis Healthcare Ltd. | 9.94% |
Lupin Ltd. | 8.86% |
Laurus Labs Ltd. | 6.91% |
Aurobindo Pharma Ltd. | 5.94% |
Alkem Laboratories Ltd. | 5.78% |
Glenmark Pharmaceuticals Ltd. | 5.31% |
Mankind Pharma Ltd. | 5.03% |
Biocon Ltd. | 4.17% |
Krishna Institute of Medical Sciences Ltd | 3.31% |
Ipca Laboratories Ltd. | 3.29% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.18% |
Divi's Laboratories Ltd. | 7.26% |
Max Healthcare Institute Ltd. | 5.62% |
Cipla Ltd. | 4.41% |
Lonza Group Ag | 4.05% |
Lupin Ltd. | 4.04% |
Acutaas Chemicals Ltd. | 3.81% |
Fortis Healthcare Ltd. | 3.76% |
Torrent Pharmaceuticals Ltd. | 3.49% |
Jupiter Life Line Hospitals Ltd. | 3.46% |
Fund Manager
Name | Kapil Menon | Tanmaya Desai |
Start Date | 02 Jun 2025 | 17 May 2024 |
Name
Kapil Menon
Tanmaya Desai
Start Date
02 Jun 2025
17 May 2024
About Fund
Description | The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 08 Apr 2024 | 04 Jun 1999 |
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
08 Apr 2024
04 Jun 1999